A patented nanoparticle production technology platform reduces the size of unprocessed paclitaxel and docetaxel crystals by up to 400 times into stable, naked nanoparticles. The 400x reduction is like reducing a basketball to the size of a pinhead. [Dallas Innovates illustration is not to scale. Artwork via istockphoto.]